Interactomes - OmicsDI

Show results for

Unknown (791)
Proteomics (459)
Genomics (193)
Transcriptomics (88)
Other (36)
Multiomics (1)
Metabolomics (1)

Organisms

Allexis (345)
Arabidopsis thaliana (345)
Bos taurus (345)
Callinectes sapidus (345)
Drosophila melanogaster (345)
Entamoeba histolytica HM-1:IMSS-A (345)
Escherichia coli (345)
Homo sapiens (345)
Leishmania major strain Friedlin (345)
Homo sapiens (143)
Mus musculus (38)
Arabidopsis thaliana (4)
Plasmodium falciparum (4)
Saccharomyces cerevisiae (3)
Drosophila melanogaster (3)
Escherichia coli (3)
Escherichia coli str. K-12 substr. MG1655 (2)
synthetic construct (2)
Klebsiella pneumoniae subsp. pneumoniae ATCC 43816 (1)
Saccharomyces cerevisiae BY4741 (1)
Trypanosoma brucei (1)
Pan troglodytes (1)
Escherichia coli K-12 (1)
121791 (1)
Gallus gallus (1)
Hendra virus horse/Australia/Hendra/1994 (1)
Mus (1)
Severe acute respiratory syndrome coronavirus 2 (1)
Taraxacum (1)
cellular organisms (1)

Organisms

Homo sapiens (93)
Mus musculus (26)
Plasmodium falciparum (4)
Escherichia coli str. K-12 substr. MG1655 (2)
Saccharomyces cerevisiae (2)
Drosophila melanogaster (2)
Klebsiella pneumoniae subsp. pneumoniae ATCC 43816 (1)
Trypanosoma brucei (1)
Sinorhizobium meliloti (1)
unidentified (1)
Escherichia coli K-12 (1)
Salmonella enterica subsp. enterica serovar Typhimurium str. SL1344 (1)
marine metagenome (1)
Saccharomyces cerevisiae BY4741 (1)
Escherichia coli (1)
Arabidopsis thaliana (1)

Repository

pride (345)
ENA (164)
geo (129)
MassIVE (67)
iProX (27)
biostudies-arrayexpress (19)
jPOST (17)
GPMDB (3)
PanoramaPublic (3)
EGA (2)
MetaboLights (1)

Tissue

Cell culture (133)
Permanent cell line cell (37)
Brain (24)
Epithelial cell (22)
Kidney (19)
Early embryonic cell (12)
Fibroblast (10)
T cell (9)
HEK-293 cell (8)
Liver (8)
Heart (7)
Primary cell (6)
Stem cell (6)
Breast (5)
Embryonic stem cell (5)
HEK-293T cell (5)
HeLa cell (5)
Hepatocyte (5)
Macrophage (5)
Blood (4)
Cell suspension culture (4)
Embryo (4)
B cell (3)
Bone marrow (3)
Lung (3)
Melanocyte (3)
Pancreas (3)
Plant cell (3)
Root (3)
Thymus (3)

Disease

Disease free (11)
Breast cancer (9)
Mixed disorder as reaction to stress (6)
Giardiasis (4)
Not Available (3)
Acute leukemia (3)
Amyotrophic lateral sclerosis (3)
COVID-19 (3)
Glioblastoma (3)
Parkinson's disease (3)
Acute myeloid leukemia (2)
Cervix carcinoma (2)
Crohn's disease (2)
Inflammatory bowel disease (2)
Leishmaniasis (2)
Melanoma (2)
Plasmodium falciparum malaria (2)
Temporal lobe epilepsy (2)
Trypanosomiasis (2)
Ulcerative colitis (2)
Normal (1)
Adenocarcinoma (1)
Bacterial infectious disease (1)
Bone cancer (1)
Coronavirus infectious disease (1)
DNA (1)
FTDALS1 (1)
Fabry disease (1)
Human immunodeficiency virus infectious disease (1)
Lewy body dementia (1)

Technology Type

Mass Spectrometry (345)
Affinity purification coupled with mass spectrometry proteomics (169)
Shotgun proteomics (107)
Bottom-up proteomics (74)
Data-dependent acquisition (55)
Data-independent acquisition (26)
Gel-based experiment (22)
Chemical cross-linking coupled with mass spectrometry proteomics (15)
Affinity proteomics (5)
SWATH MS (5)
Top-down proteomics (5)
DiaPASEF (2)
SRM/MRM (2)
ILLUMINA, Illumina HiSeq 2000 (1)
Mass spectrometry (1)
All-ion fragmentation (1)
HDMSE (1)
Immunopeptidomics (1)

Instrument Platform

Orbitrap Fusion (7)
Orbitrap Fusion Lumos (6)
LTQ (5)
LTQ Orbitrap Elite (5)
Orbitrap Exploris 480 (5)
Q Exactive HF (5)
Q Exactive Plus (5)
Orbitrap Eclipse (4)
TripleTOF 5600 (4)
Instrument (3)
LTQ Orbitrap Velos (3)
TimsTOF Pro (3)
TimsTOF Pro 2 (3)
Illumina NovaSeq 6000 (2)
LTQ Orbitrap (2)
Q Exactive (2)
TimsTOF HT (2)
Illumina-compatible library preparation equipment (1)
Monarch RNA purification column system (1)
Standard mammalian cell culture equipment (1)
NextSeq 550 (1)
Illumina HiSeq 4000 (1)
ACQUITY UPLC (1)
LTQ XL (1)
Orbitrap Fusion Tribrid mass spectrometer (1)
Orbitrap QE-plus (1)
QSTAR XL (1)
TimsTOF SCP (1)
TripleTOF 6600 (1)
Liquid Chromatography MS - negative - reverse phase (1)

Publication Date

2025 (97)
2026 (84)
2023 (75)
2024 (71)
2022 (69)
2021 (48)
2019 (34)
2020 (27)
2018 (21)
2016 (18)
2017 (17)
2015 (14)
2013 (12)
2014 (11)
2012 (5)
2009 (2)

CHEBI ID

CHEBI:166925 (1)
CHEBI:60880 (1)
CHEBI:75003 (1)
CHEBI:71029 (1)
CHEBI:74072 (1)
CHEBI:74751 (1)
CHEBI:456215 (1)
CHEBI:137259 (1)
CHEBI:75011 (1)
CHEBI:74561 (1)
CHEBI:73823 (1)
CHEBI:75012 (1)
CHEBI:74327 (1)
CHEBI:6426 (1)
CHEBI:53013 (1)
CHEBI:28223 (1)
CHEBI:17256 (1)
CHEBI:74795 (1)
CHEBI:75013 (1)
CHEBI:75016 (1)
CHEBI:16192 (1)
CHEBI:28635 (1)
CHEBI:27652 (1)
CHEBI:18186 (1)
CHEBI:16811 (1)
CHEBI:73591 (1)
CHEBI:15956 (1)
CHEBI:73527 (1)
CHEBI:73589 (1)
CHEBI:73605 (1)

Metabolite Name

Guanosine-5'-Monophosphate (5'GMP) (1)
Adenosine 3'-monophosphate (3'AMP) (1)
2-Deoxyadenosine 5-monophosphate (dAMP) (1)
Uridine 5'-monophosphate (5'UMP) (1)
Cytidine 3'-monophosphate (3'CMP) (1)
Cytidine 2':3'-Cyclic monophosphate (2', 3'-cCMP) (1)
2'-Deoxycytidine 5'-monophosphate (dCMP) (1)
N-Formyl-L-Methionine (1)
Leu-Ala (1)
2-Isopropylmalic acid (1)
Adenosine (1)
NADH (1)
Guanosine (1)
Biotin (1)

First Public Date

2025 (33)
2026 (25)
2023 (18)
2022 (17)
2021 (16)
2024 (14)
2019 (10)
2015 (6)
2016 (5)
2013 (5)
2020 (4)
2018 (4)
2017 (4)
2014 (3)

Classification

bacteria (6)
protozoa (5)

Modification

2x(15)N labeled L-lysine (2)
4-tetrahydrothiazine-3-carboxylic acid (2)
4x(15)N labeled L-arginine (2)
0.984016 (1)
15.994915 (1)
42.010565 (1)
57.021464 (1)

Study type

ChIP-seq (4)
RNA-seq of coding RNA (4)
Other (3)
Transcription profiling by array (2)
ChIP-chip by tiling array (1)
Cell line - One-color microarray (1)
Transcription profiling by tiling array (1)
ChIP-chip by array (1)
RNA-seq of total RNA (1)
RNA-seq of non coding RNA (1)

Release Date

2023 (101)
2022 (91)
2025 (85)
2024 (83)
2021 (76)
2020 (59)
2019 (54)
2017 (41)
2015 (34)
2018 (33)
2016 (32)
2013 (29)
2012 (26)
2014 (19)
2026 (13)
2010 (8)
2011 (7)
2009 (6)
2008 (6)
2007 (3)
2006 (3)
2002 (1)

Lab affiliation

EDyP (8)
Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02215, USA., Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 02115, USA (6)
Proteomics Core Facility and Research Group Proteomics, CEITEC-MU, Masaryk University, Brno, Czech Republic (5)
Berlin Institute of Health at Charite, Universitaetsmedizin Berlin, Core Facility Proteomics; Max Delbrueck Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin, Germany (4)
IMSB, ETH Zurich (4)
School of Biological Sciences, Department of Cell and Developmental Biology, University of California, San Diego, CA, USA (4)
Department of Plant Systems Biology, University of Hohenheim, 70599 Stuttgart, Germany (3)
Institute of Pharmacology and Structural Biology, CNRS, Toulouse, France (3)
Key Laboratory of Brain Functional Genomics of Shanghai and Ministry of Education, Institute of Brain Functional Genomics, School of Life Science and the Collaborative Innovation Center for Brain Science, East China Normal University, Shanghai, China (3)
Laboratory of Molecular Parasitology, Institute of Parasitology, University of Zurich, Switzerland (3)
Max Perutz Labs, Department of Microbiology, Immunobiology and Genetics, Center for Molecular Biology, University of Vienna (3)
University of Southern California (3)
Buchmann Institute of Molecular Life Sciences and Institute of Biophysical Chemistry, Goethe University, Frankfurt am Main, Germany (2)
CRUK Beatson Institute, Switchback Road, Glasgow G61 1BD, UK. (2)
Chemistry Department, Columbia University in the City of New York (2)
Chemistry Department, Wayne State University, US (2)
Department of Biology – Cellular Proteostasis and Mass Spectrometry, University of Konstanz (2)
Department of Cell Biology and Physiology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599 (2)
Department of Medicine, Columbia University Irving Medical Center (2)
Department of Molecular Biology, Faculty of Science, Radboud Institute for Molecular Life Sciences (RIMLS), Oncode Institute, Radboud University Nijmegen, 6525 GA Nijmegen, The Netherlands Division of Molecular Genetics, The Netherlands Cancer Institute, 1066CX, Amsterdam, The Netherlands (2)
Department of Radiological Medicine, School of Basic Medical Sciences, Chongqing Medical University (2)
Department of Systems Immunology, Weizmann Institute of Science, Rehovot, Israel (2)
Head of the Curie Institute Mass Spectrometry Platform (2)
Institute for Transformative Molecular Medicine and Department of Medicine, Case Western Reserve University School of Medicine, Cleveland, OH 44106, USA Harrington Discovery Institute, University Hospitals Cleveland Medical Center, Cleveland, OH 44106, USA (2)
Koç University, Department of Molecular Biology and Genetic Cell Biology Lab head (2)
Ori Research Group, The Leibniz Institute on Aging – Fritz Lipmann Institute, Jena, Germany (2)
School of Biological Sciences,Department of Cell and Developmental Biology, University of California, San Diego, CA, USA (2)
Systems Arbovirology, Leibniz Institute of Virology, Hamburg, Germany (2)
TIGEM (2)
UMR 7367 CNRS-UL IMoPA Biopôle de l'Université de Lorraine Campus Brabois-Santé 9 avenue de la forêt de Haye 54505 Vandoeuvre-les-Nancy FRANCE (2)

Previous page
1 / 157
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 157
Next page

Sort by:

Relevance

Page size

Generalized and social anxiety disorder interactomes show distinctive overlaps with striosome and matrix interactomes.

Not available

S-EPMC8443595 | biostudies-literature

GSK-3 Interactomes from APMS and BioID

Interactomes of GSK-3 Isoforms compared by APMS (in HEK293) and BioID (in HEK293 and HeLa cells).

ORGANISM(S): Homo Sapiens (ncbitaxon:9606)

2022-12-15 | MSV000090908 | MassIVE

Click-enabled analogues reveal pregnenolone interactomes in cancer and immune cells

Click-enabled analogues reveal pregnenolone interactomes in cancer and immune cells. TMT-6 experiment of tryptic, carbamidomethylated peptides of mouse CD8+ T-cells after protein pull-down on pregnenolone beads.

ORGANISM(S): Mus musculus (Mouse)

2021-04-26 | PXD025574 | Pride

Pregnenolone pull-down cd8+ t-cells